Improving Prediction & Translation of ADC Toxicities to Drive More Tolerable ADCs Successfully Into & Through Clinical Development Toxicities continue to pose the most significant challenge in the ...
AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis as a treatment for a type of lung cancer. The US regulator cleared Emrelis ...
SPG Simon Property Group, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results